Novartis Investigative Site

Bennington, Vermont 05201

0 studies enrolling now · 3 studies all time

What they study most

Alzheimers Disease, Cardiovascular Disease, Major Depressive Disorder, Type 2 Diabetes Mellitus

Studies at this site

• A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early